Table 1.

Clinical Features of Intestinal Allograft Recipients

	Isolated intestine	Composite graft	Total
Total no. of patients	35	63	98
Children/adults	16/19	43/20	59/39
Age (y)
Children*	8 ± 5	4±4	5 ± 5
Adults	36 ± 11	32 ± 9	34 ± 10
Male/female	16/19	34/29	50/48
Duration of TPN (mo)	53 ± 47	39 ± 41	44 ± 43
Total bilirubin (mg/dL)*	1.2 ± 0.7	17.4 ± 14	12 ± 14
No. of abdominal operations*	5.1 ± 4.3	2.7 ± 2.2	3.6 ± 3.3
Operative time (h)*	12 ± 4	15 ±4	14 ±4
No. of allografts	37	67	104
Cold ischemia time (h)*	7 ± 2	9 ± 3	8±3
HLA (-A, -B, -DR) mismatch	4.5 ± 1.2	4.7 ± 1.1	4.6 ± 1.1
Positive cross-match	3 (8%)	10 (15%)	13 (13%)
Bone marrow augmentation	8 (22%)	12 (18%)	20 (19%)
Followup (mo)	23 ± 21	24 ± 26	24 ± 24

^*p < 0.05.

HLA, human leukocyte antigen; TPN, total parenteral nutrition.